Hormone—receptor interactions Stimulation and inhibition of bovine adrenal cortex cell membrane adenylate cyclase by synthetic corticotropin fragments and the effect of 5′-guanylylimidodiphosphate  by Bonnafous, Jean-Claude et al.
Volume 78, number 2 FEBS LETTERS June 1977 
HORMONE-RECEPTOR INTERACTIONS 
Stimulation and inhibition of bovine adrenal cortex celI membrane adenylate cyclase by 
synthetic corticotropin fragments and the effect of 5’-guanylylimidodiphosphate 
Jean-Claude BONNAFOUS, Jean-Luc FAUCHERE, Werner SCHLEGEL and Robert SCHWYZER 
Institu t fiir Molekularbiologie und Biophysik, Eidgeniissische Technische Hochschule, CH-8093 Ziirich, Switzerland 
Received 7 April 1977 
Revised version received 23 April 1977 
1. Introduction 
Recently, the differential action of corticotropin 
fragments on rat epididymal adipocyte membrane 
adenylate cyclase activity and rat adipocyte lipolysis 
was described [ 1 ] . It was also found in this laboratory 
that the benzyloxycarbonyl derivatives of two of the 
fragments were active in a purified preparation of 
bovine adrenal cortex plasma membrane vesicles con- 
taining a highly corticotropin-sensitive adenylate 
cyclase system and angiotensin-II-binding sites [2]. 
Before [3] and during these studies it became 
increasingly clear that high concentrations of cortico- 
tropin peptides trongly inhibit the stimulation of 
membrane adenylate cyclase activity. 
Because this type of investigation can provide new 
information on the mechanism of corticotropin action 
(review [4] ), we decided to study the effects of the 
corticotropin peptides hown in table 1 with the 
bovine adrenal system. The synthesis of these peptides 
was described by Fauchere and Petermann [5]. 
Since it is known that 5’.guanylylimidodiphosphate 
stimulates the adenylate cyclase activity and modulates 
its reponses to hormones in a number of systems 
(review [6 ] ), including adrenal cortex cell membranes 
[7] , the effects of this nucleotide analogue were also 
investigated. 
2. Experiments 
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laboratory by classical chemical synthesis and were 
analytically pure [S] . The preparation of purified 
bovine adrenal cortex plasma membrane vesicles con- 
taining a highly corticotropin-sensitive adenylate 
cyclase system and angiotensin-II-binding sites were 
carried out according to the procedures used in our 
laboratory [2]. Adenylate cyclase activity was 
measured by a modification [2] of the method of 
Salomon et al. [12] with 0.5 mM ATP. We did not 
preincubate the vesicles with the peptides: the 
preparation responded immediately (see however 
[7] ). The corticotropin peptide stock solutions were 
diluted shortly before application. This diminished 
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the losses due to adsorption and hence increased the 
observed apparent potencies. 
Experimental values were derived from 3 deter- 
minations within one and the same xperiment. In 
tig.2, they represent the means of the values obtained 
from 2-3 experiments with different vesicle prepara- 
tions. The 5’guanylylimidodiphosphate concentrations 
varied somewhat from experiment to experiment, but 
were always ufficient o produce maximal effects 
PI. 
For the purpose of comparing different experiments 
(as in fig.2), the adenylate cyclase activities were 
normalized to their basal rates, i.e. expressed as the 
ratio stimulated rate : basal rate. 
The hormone concentration ecessary for eliciting 
50% of the maximal response (ED,,) was determined 
graphically. 
3. Results and discussion 
3.1. Effects of 5’-gwnylylimidodiphosphate (GppNHp) 
This analogue of guanosine 5’-triphosphate stimulates 
adenylate cyclase activity in a number of systems 
[6] , including membrane preparations of the adrenal 
cortex [7] . The log dose/response curves of cortico- 
tropin peptides are sometimes modified quite con- 
siderably by the presence of GppNHp, especially with 
rat, less so with bovine adrenal preparations [7] . 




Fig. 1. Influence of 5’-guanylylimidodiphosphate on bovine 
adrenal cortex cell membrane adenylate cyclase activity. 
Curves 1 without, curves 2 with 10 PM corticotropin-(1-24)- 
tetracosapeptide. In the experiments (b), 5’-guanylylimido- 
diphosphate was added at f = 4 min to a concentration of 
36 PM, in experiments (a), the nucleotide was omitted. 
(i) GppNHp enhances both the basal and the cortico- 
tropin-stimulated rates of cyclic AMP production 
by bovine adrenal cortex cell membrane adenylate 
cyclase with about equal increments. 
(ii) Thus, the relative nhancement of the basal 
activity by GppNHp is greater than that of the 
corticotropin-stimulated activity. 
(iii) The GppNHp effect increases with time, or, in 
other terms, exhibits a protracted latency period 
of action. 
These results agree in principle with those described 
for other [8] and similar [7] adenylate cyclase systems. 
EDso was found to be ” 0.05 PM without and 
!X 0.02 PM with GppNHp. The slight difference is 
most probably insignificant. This result agrees with 
the observations of Glossman and Gips [7]. The 
modification of hormone activity produced by 
GppNHp in these experiments ( ee also fig.2) is very 
small compared to its modulation of fl-adrenergic 
activity [9]. Because of the precautions taken to 
limit the adsorption of peptide 1 to recipients, we 
found EDse to be about lo-times smaller than that 
observed previously [2] and comparable to that 
described elsewhere [7]. 
3.2. Effects of the corticotropin analogues 
Synthetic orticotropin-(1-24)tetracosapeptide 
(peptide 1) is a full agonist and at least as potent as 
the natural hormone, corticotropin-(1-39)nonatria- 
contapeptide, in all experimental systems comprising 
isolated cells and cell membranes (review [4] ). The 
shorter peptide 5, peptide 6 and peptide 7 were found 
to be almost equal partial agonists for rat epididymal 
fat celI (adipocyte) membrane adenylate cyclase 
activation [1,101 with potencies imilar to that of 
peptide 1. However, despite stimulation of adenylate 
cyclase by all compounds, only peptide 5 stimulated 
lipolysis in adipocytes; the others behaved as com- 
petitive antagonists of peptide l-stimulated lipolysis. 
The N(o)-benzyloxycarbonyl derivatives of peptide 5 
and peptide 7 (Z-5 and Z-7) behaved similarly. Z-5 and 
Z-7 were also reported to stimulate bovine adrenal 
cortex cell membrane adenylate cyclase activity 
partially [2] . 
Three principal features of bovine adrenal cortex 
ceII adenylate cyclase stimulation by peptide 1, 
peptide 5, peptide 6 and peptide 7 immediately become 
apparent from the experiments summarized in fig.2: 
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Thus, the reduced-chain peptides, with the 
exception of peptide 8, appear to be partial agonists for 
bovine adrenal cortex cell adenylate cyclase activa- 
tion. Their intrinsic activities are about equal. How 
much importance, if any, can be attached to the 
observed ifferences between their EDse values, is 
uncertain. More than 20.fold differences due to vary- 
ing preincubation times have been demonstrated by 
Glossman and Struck [7]. In addition, it might well 
be that differential rates of adsorption to glassware, 
degradation rates, and inhibitory powers influence the 
observed EDse values quite markedly. It is thus 
probably safe to say that the potencies of peptide 1, 
peptide 5, peptide 6 and peptide 7 have the same 
order of magnitude. -kg dtse n-d/l hamone 
Fig.2. Log dose/response curves for the stimulation of bovine 
adrenal cortex cell membrane adenylate cyclase activity by 
synthetic corticotropin fragments numbered as shown in 
table 1. The results of different experiments were calculated 
as ratios of stimulated over basal (non-stimulated) cyclic AMP 
production/mg protein/l5 min. Curves (a) were derived from 
experiments without, curves (b) from experiments with addi- 
tion of 2-10 bM S’guanylylimidodiphosphate. 
(i) The 4 peptides are active within about the same 
concentration range. 
(ii) They all inhibit adenylate cyclase at high con- 
centrations of the peptide, some of them even to 
values below the basal rate. 
(iii) GppNHp has no profound influence on the 
behaviour of either one of these peptides. 
In the presence of GppNHp, peptide 1 displays a 
mean maximal adenylate cyclase stimulation of 3.2. 
fold over the basal values. This value was taken as the 
reference apparent intrinsic activity (cr = lb Its 
(reference) potency is in the order of 3.3 X 10’ M-’ 
(EDs,, ” 0.03 MM). 
Peptide 5 is about 20.times less potent than 
peptide 1 (EDso 2 0.6 PM) and only a 20% partial 
agonist (o = 0.2) in the presence of GppNHp. In its 
absence, EDso N 0.7 PM and o ” 0.3 i
Peptide 6 is about 13.times less potent than 
peptide 1 (EDse z 0.4 PM) with a! ” in the presence 
of GppNHp. 
Peptide 7 is even about twice as potent as peptide 1 
(ED5e N 0.013 PM) with a! 2 0.22 both in the presence 
and absence of GppNHp. 
Peptide 8 is inactive. 
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3.3. Inhibition of adenylate cyclase activity with high 
concentrations of corticotropin peptides 
The inhibition of corticotropin-stimulated a ipocyte 
membrane adenylate cyclase activity down to basal 
values by high concentrations of peptide 1 has been 
described by Lang [3]. It was shown that phenoxa- 
zones, which increase the maximal effect and the 
number of receptors per cell, do not influence the 
inhibition phenomenon. Similar effects have been 
observed with adrenal cortex cell membrane adenylate 
cyclase preparations and corticotropin peptides [2,7]. 
In the case of bovine adrenal cortex cell membrane 
vesicles (fig.2), a vesicle aggregation was often 
observed both visually and with dynamic light 
scattering (J. Moran and E. Serrallach, unpublished 
experiments in this laboratory). The questions arised 
as to whether the inhibition was reversible and to 
whether the aggregation is responsible for the inhibi- 
tory effect. 
Figure 3 shows that a 25.fold dilution from 
250-10 PM peptide 1 almost fully restores the 
activity. The aggregation of the vesicles, however, 
remained visibly unchanged. Addition of GppNHp 
without dilution of the hormone was ineffective. 
4. Conclusions 
The membrane adenylate cyclase activities of bovine 
adrenal cortex and of rat epididymal fat pads respond 
very similarly towards the peptides examined here. The 
adrenal system is strongly stimulated by corticotropin- 
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Experiments A.B.C.D.and E 
Fig.3. Inhibition and restoration of bovine adrenal cortex 
cell membrane adenylate cyclase activity. (A) Non-stimulated, 
basal activity. (B) Stimulation by 10 PM peptide 1. (C) 
Stimulation by 250 MM peptide 1 after preincubation for 5 min 
with 500 PM hormone. (D) Stimulation by 10 PM peptide 1 
after preincubation as in (C). (E) As in (C) but with addition 
of 50 PM S’guanylylhnidodiphosphate after the preincubation 
with hormone. 
(1-24)tetracosapeptide (peptide 1) and partially so 
by peptides with shorter N-terminal sequences: 
corticotropin-(5-24)icosapeptide (peptide 5), cortico- 
tropin-(6-24)nonadecapeptide (p ptide 6), and 
corticotropin-(7-24)octadecapeptide (p ptide 7). 
However, the peptide lacking phenylalanine, cortico- 
tropin@-24)heptadecapeptide (peptide 8) is inactive. 
The responses of the adrenal enzyme are only slightly 
modulated by S’guanylylimidodiphosphate. 
The strong inhibition of stimulated (and even basal) 
membrane adenylate cyclase activity by high cortico- 
tropin peptide concentrations (lo-250 nM peptide 1, 
peptide 5, peptide 6 and peptide 7) is a property 
common to both systems. Its mechanism remains 
unknown. As a consequence, great care must be 
exercised when interpreting data from inhibition 
experiments: an agonist at low concentrations 
(< l-l 0 PM) will inevitably turn into an antagonist 
at high concentrations (> 10 PM) and any slight 
intrinsic stimulatory activity might become almost 
completely obscured by the inhibitory effect. 
These apparently quite general inhibitory properties 
may help to explain the recent observations of Finn 
et al. [l l] that certain corticotropin analogues which, 
at concentrations of lo-180 fi, antagonize the 
action of peptide 1 upon bovine adrenal cortex cell 
membrane adenylate cyclase are nervertheless able to 
elicit cyclic AMP accumulation and steroiddgenesis in 
whole cells. 
The implications of this experimental work for the 
theories of one-dimensional organization of informa- 
tion in corticotropin [4] and of mediation by cyclic 
AMP shall be dealt with elsewhere [lo] . 
Acknowledgements 
This work was supported by the ‘Schweizerischer 
Nationalfonds zur Forderung der wissenschaftlichen 
Forschung’. J C.B. was a recipient of NATO and 
EMBO Fellowships (present address: E.N.S. Chimie, 
8, Rue de 1’Ecole Normale, F-34075 Montpellier). We 
thank Miss Ursula Walty for technical assistance and 
Miss Ruth Kuhn for typing the manuscript. 
References 
[ 11 Lang, U., Fauchere, J. L., Pelican, G. M., Karlaganis, G. 
and Schwyzer, R. (1976) FEBS Lett. 66,246-249. 
[2] Schlegel, W. and Schwyzer, R. (1977) Eur. J. Biochem. 
72,415-424. 
[3] Lang, U. (1973) Dissertation No. 5215, ETH Zurich; 
Lang, U. and Schwyzer, R. (1976) in: Peptide Hormones 
(Parsons, J. A. ed) pp. 337-348, Macmillan Press Ltd, 
London. 
[4] Schwyzer, R. (1977) Annals NY Acad. Sci. in press. 
[5] Fauchere, J.-L. and Petermann, C. (1977) Helv. Chim. 
Acta in press. 
[6] Rodbell, M., Lin, M. C., Salomon, Y., Londos, C., 
Harwood, J. P., Martin, B. R., Rendell, M. and Bermon, 
M. (1975) Adv. Cyclic Nucleotide Res. 5, 3-29. 
[7] Glossmann, H. and Gips, H. (1974) Naunyn- 
Schmiedeberg’s Arch. Pharmacol. 286,239-249; 
(1975) 289,77-97; Glossmann, H. (1975) ibid. 289, 
99-109; (1975) 291,89-100; Glossmann, H. and 
Struck, C. J. (1976) ibid. 294, 199-206. 
[8] RodbeB, M. (1975) J. Biol. Chem. 250,5826-5834; 
Salomon, Y., Lin, M. C., Londos, C., Rendell, M. and 
Rodbell, M. (1975) ibid. 4239-4245. 
[9] Lefkowitz, R. J., MuLtikin, D. and Caron, M. G. (1976) 
J. Biol. Chem. 251,4686-4692. 
[lo] Schwyzer, R. et al., in preparation. 
[ 111 Finn, F. M., Johns, P. A., Nishi, N. and Hofmann, K. 
(1976) J. Biol. Chem. 251,3576-3585. 
[ 121 Salomon, Y., Londos, C. and Rodbell, M. (1974) Anal. 
Biochem. 58,541-548. 
250 
